US Patent Issued to AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION on Feb. 10 for "Pharmaceutical composition for preventing or treating Behcet's disease and rheumatoid arthritis, containing peptide or mixture thereof as active ingredient" (South Korean Inventor)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,706, issued on Feb. 10, was assigned to AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (Suwon-si, South Korea).

"Pharmaceutical composition for preventing or treating Behcet's disease and rheumatoid arthritis, containing peptide or mixture thereof as active ingredient" was invented by Seonghyang Sohn (Suwon-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a composition for preventing or treating Behcet's disease and rheumatoid arthritis, the composition containing a peptide or a mixture thereof as an active ingredient. More specifically, an intraperitoneal injection or application of P1 to P5 ...